Operating Activities | |
Net Income | 385M |
Adjustments to reconcile net income to net cash from operating activities: | |
Depreciation, depletion and amortization | 472M |
Deferred income taxes | 134M |
Assets losses, reserves and impairments, net | |
Changes in assets and liabilities, exclusive of changes shown separately (Note 13) | |
Net cash from operating activities | 1.27B |
Investing Activities | |
Plant and equipment expenditures - utility | |
Plant and equipment expenditures - non-utility | |
Proceeds from sale of assets, net | 0 |
Restricted cash for debt redemption | 1M |
Proceeds from sale of nuclear decommissioning trust fund assets | |
Investment in nuclear decommissioning trust funds | |
Consolidation of VIEs | |
Other | 39M |
Net cash used for investing activities | -938M |
Financing Activities | |
Issuance of long-term debt | 588M |
Redemption of long-term debt | -313M |
Short-term borrowings, net | -324M |
Issuance of common stock | 0 |
Repurchase of common stock | -33M |
Dividends on common stock | -262M |
Other | 5M |
Net cash used for financing activities | -339M |
Net Increase (Decrease) in Cash and Cash Equivalents | -5M |
Cash and Cash Equivalents at Beginning of Period | 37M |
Cash and Cash Equivalents at End of Period | 32M |